Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07434869
Eligibility Criteria:
Inclusion Criteria:
* Adults (≥18 years) or pediatric patients (7-17 years) who have had a single or double lung transplant
* Diagnosed with CLAD (any stage) and prescribed ECP therapy
* Ability to provide informed consent (or assent with parental consent for minors)
Exclusion Criteria:
* Previously received ECP treatment
* Receipt of anti-thymocyte globulin within 3 months or alemtuzumab within 12 months of ECP initiation
* Contraindications to MRI (for MRI subgroup), including metal implants, claustrophobia, seizure disorder
* Known allergy to gadolinium or impaired kidney function (eGFR \<30 ml/min)
* Pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Study:
NCT07434869
Study Brief:
Protocol Section:
NCT07434869